Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice ; year:2021
European journal of immunology ; (2021)

Creator: Stoycheva, Diana
Sandu, Ioana
Gräbnitz, Fabienne
Amorim, Ana
Borsa, Mariana
Weber, Stefan
Becher, Burkhard
Oxenius, Annette

DOI: 10.1002/eji.202049068

URN: urn:nbn:de:101:1-2021022407234148180706

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Stoycheva, Diana
Sandu, Ioana
Gräbnitz, Fabienne
Amorim, Ana
Borsa, Mariana
Weber, Stefan
Becher, Burkhard
Oxenius, Annette

Other Objects (12)

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Impact of Sleep on Monocytes and Infection

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Impact of Sleep on Monocytes and Infection

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Impact of Sleep on Monocytes and Infection

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Impact of Sleep on Monocytes and Infection

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Impact of Sleep on Monocytes and Infection

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies

Impact of Sleep on Monocytes and Infection

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Related objects

Reset password